Genome Medical

Genome Medical

Private
South San Francisco, CaliforniaHealthcare & Life Scienceshttps://www.genomemedical.com

Last Round

Series D

Sep 10, 2024

Est. Valuation

$39M

Total Funding Raised

$195.34M

Company Overview

Genome Medical is a genomic medicine company that connects individuals and healthcare providers to genetic experts, offering genetic assessments and personalized clinical action plans to enhance precision healthcare and facilitate informed treatment decisions.

Sector

Healthcare & Life Sciences

Verticals

Telemedicine, Precision Medicine, Vertical SaaS, Clinical Trials

Business Model

B2B2C

Customer Profile

Services & Consulting, Subscription SaaS, Data as a Service

AI Layer

Application

Keywords

virtual genetic counselingtele-genetic counselinggenomic medicinetelehealth platformgenetic test interpretationprecision medicinevirtual genetics clinicgenetic specialist networkpharmacogenomicspersonalized medicinegenetic test orderingpersonalized care plansprovider consultationsgenomic care deliveryclinical trial matching

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Genome Medical Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Genome Medical Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series DSep 10, 2024
Series CAug 30, 2021
Series B ExtensionJul 1, 2020
Series BJun 11, 2019
Series AJan 5, 2018
Series A
May 29, 2017

Key People

Founding team and executive leadership

Jill Davies

Chief Executive Officer

Executive Team

Mark Sylvester

COO CFO

Executive Team

Genome Medical Investors

Notable investors and investment history

InvestorRounds
GVSeries C
Perceptive AdvisorsSeries C, Series B Extension, Series B
Kaiser Permanente VenturesSeries C, Series B Extension, Series B, Series A
Manatt VenturesSeries B Extension
Avestria VenturesSeries C, Series B Extension
Dreamers VCSeries C, Series B Extension
Amgen VenturesSeries C

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 3, 2025

    Recognized as one of the Top 50 in Digital Health.

  • Jan 17, 2025

    Partnered with Nest Genomics to expand genetic services access.

Genome Medical Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Genome Medical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Genome Medical's valuation, stock price, and market status.

Firmographic Details

HeadquartersSouth San Francisco, California
Employee Range81
Year Founded2016
Last FundingSep 10, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.